SLEEVE GASTRECTOMY WITH DUODENAL SWITCH- Gastroenterologist in Nagercoil
Sleeve gastrectomy with duodenal switch is a type of bariatric surgery, which is used to treat severe obesity this type of surgery has become popular in recent years because it is more effective than other types of bariatric surgeries. Our gastroenterologist in Nagercoil can help obese people lose weight by limiting the size of their stomach and reducing hunger and cravings for food.
Sleeve gastrectomy with duodenal switch does not require any incisions on the abdomen or intestines. This helps make it less invasive than other types of bariatric surgeries and makes it a better option for obese people who are not comfortable with surgeries that require them to go under general anaesthesia. In Barioss we are offering weight surgeries with best gastroenterologist in Tirunelveli.
GASTRIC STIMULATION
Gastric stimulation is a surgical procedure in which an implantable device is implanted in the stomach to send electric pulses to the vagus nerve, which then sends signals to the brain that make you feel full.
This surgery has been around since 1967 but it was only recently approved by the FDA in 2013. It’s a less invasive and more reversible option for weight loss than other surgeries, such as gastric bypass or lap band surgery. However, it does not address issues like overeating late at night or emotional eating, so people who have these issues may need additional treatments after this surgery.
REDUCED MORTALITY AND MORBIDITY
The mortality rate of patients who have undergone bariatric surgery is lower than the general population. And the morbidity of these patients is also reduced.
Weight loss following bariatric procedures is linked to a reduction in various obesity-related comorbidities, such as diabetes, metabolic syndrome, and sleep apnea, in the short term, although the impact of hypertension is unclear. It’s unclear whether one bariatric procedure is more beneficial than another in terms of comorbidity management. There is no high-quality information on the long-term impact of comorbidity treatment when compared to traditional treatment.
When compared to non-operated control patients with obesity, bariatric surgery has been linked to a longer life expectancy. Given the high rate of diabetes remission associated with bariatric surgery, there is a lot of interest in providing this treatment to persons with type 2 diabetes who have a lower BMI than is typically necessary for bariatric surgery, however, there isn’t enough high-quality evidence.